Sharda Cropchem Limited, a leading player in the crop protection chemicals industry, reported a robust performance for the third quarter and nine months ended December 31, 2025, driven by strong volume growth, favourable product mix, and accelerating registrations.
For Q3 FY26, consolidated revenue surged 39% year-on-year to Rs. 1,288.8 crore, while gross profit jumped 48% to Rs. 450.3 crore, supported by margin expansion. EBITDA rose 59% to Rs. 245.5 crore, with margins improving by 250 basis points to 19.1%. Profit after tax saw a sharp jump of 366% to Rs. 145.1 crore, reflecting operating leverage and improved pricing dynamics.
The strong quarterly performance capped an exceptional nine-month run. For 9M FY26, revenue grew 29% to Rs. 3,202.7 crore, while EBITDA climbed 64% to Rs. 526.7 crore. PAT surged 259% to Rs. 362.3 crore, marking the highest-ever annual PAT achieved by the Company within the first nine months of a financial year.
Europe emerged as the standout growth engine, with agrochemical revenues in the region more than doubling in Q3 and rising 54% over the nine-month period. Product-wise, fungicides led growth with a 71% YoY increase in Q3, followed by strong gains in herbicides and insecticides. The agrochemical segment continued to anchor performance, contributing 87% of revenues in 9M FY26.
Commenting on the results, Ramprakash Bubna, Chairman and MD, said, “In Q3 FY26, we delivered robust revenue growth of 39% YoY to Rs. 1,289 crores, mainly driven by a mix of volume and product mix. Europe has led as the key contributor in both volume and value terms.
"With input costs stabilizing, improving price dynamics and change in product mix, the Company’s Gross Margins has expanded by 220 basis points to 34.9% and we expect GP Margins to remain in a similar range going ahead. We expect prices to go up going forward. EBITDA has grown by 59% to Rs. 246 crores with EBITDA Margins at 19.1%, an increase of 250 basis points on Y-o-Y basis.
"For 9M FY26, revenues grew 29% to Rs. 3,203 crore with EBITDA increasing 64% to Rs. 527 crore. The Company has already achieved its highest-ever annual PAT within the first nine months of FY26 of Rs. 362 crores. The Company expects the growth momentum to continue in Q4 FY26 and remain strong in FY27.”
Operationally, overall volumes increased 20.2% YoY in 9M FY26, while the Company continued to strengthen its long-term growth pipeline. Product registrations stood at 3,004, with 1,076 applications pending at various stages as of December 31, 2025. Capital expenditure for the nine-month period totalled Rs. 399 crore.
Sharda Cropchem remained debt-free, closing the period with cash, bank balances and liquid investments of Rs. 826 crore. Reflecting confidence in its performance and balance sheet strength, the Company declared an interim dividend of Rs. 6 per equity share.
With strong momentum across key markets, improving margins, and a healthy pipeline of registrations, Sharda Cropchem said it expects growth to remain strong through Q4 FY26 and into FY27.
